Changming Xie

1.2k total citations · 1 hit paper
20 papers, 521 citations indexed

About

Changming Xie is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Changming Xie has authored 20 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Changming Xie's work include Cardiovascular Function and Risk Factors (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Changming Xie is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Changming Xie collaborates with scholars based in China, Macao and Hong Kong. Changming Xie's co-authors include Hongchi Jiang, Shangha Pan, Jiabei Wang, Tongsen Zheng, Boshi Sun, Yingjian Liang, Shijie Zhu, Lianxin Liu, Dalong Yin and Jihua Han and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Molecular Cancer.

In The Last Decade

Changming Xie

19 papers receiving 519 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study

2023 114 citations Tao Yan, Shijie Zhu et al. Journal of the American Heart Association profile →

Peers

Changming Xie

CCM

SURGE

ONCOL

Li‐Chiu Wu Taiwan

Limin Lun China

Xinyue Wang China

Mustafa Altınbaş Türkiye

Maryam Ghandehari Iran

Hüseyin Engin Türkiye

Mathieu R. Brodeur Canada

Liyong Zhu China

Urszula Zurawska Canada

Soichiro Tajima Japan

Li‐Chiu Wu Taiwan

Changming Xie

261 ×1.3

132 ×1.2

CCM

97 ×0.9

84 ×0.8

SURGE

119 ×1.4

ONCOL

Citations per year, relative to Changming Xie Changming Xie (= 1×) peers Li‐Chiu Wu

Countries citing papers authored by Changming Xie

Since Specialization

Citations

This map shows the geographic impact of Changming Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changming Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changming Xie more than expected).

Fields of papers citing papers by Changming Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changming Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changming Xie. The network helps show where Changming Xie may publish in the future.

Co-authorship network of co-authors of Changming Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Changming Xie. A scholar is included among the top collaborators of Changming Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changming Xie. Changming Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Dajiang, Mingxuan Zhang, Zhen Zhou, et al.. (2025). Inhibition of long interspersed nuclear element-1 by nucleoside reverse transcriptase inhibitors attenuates vascular calcification. Signal Transduction and Targeted Therapy. 10(1). 321–321. 1 indexed citations

Song, Shanshan, Changming Xie, Ying Zhang, et al.. (2025). Long-Term In Vivo Administration of Panaxynol Alleviates Diabetes-Induced Vascular Calcification by Modulating Sirt6-Mediated sEH Function in Perivascular Adipose Tissue. Journal of Agricultural and Food Chemistry. 73(29). 18268–18279.

Xie, Changming, Shan Jiang, Qiong Wu, et al.. (2024). Inhibiting PI3K/AKT/mTOR signaling by metal-organic frameworks for overcoming multiple drug resistance in chemoradiotherapy. Science China Materials. 67(5). 1631–1645. 8 indexed citations

Han, Jihua, Changming Xie, Bo Liu, et al.. (2023). Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c‐Myc‐mediated glycolysis. Cancer Science. 114(12). 4535–4547. 6 indexed citations

Yan, Tao, Shijie Zhu, Changming Xie, et al.. (2023). Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study. Journal of the American Heart Association. 12(6). e027852–e027852. 114 indexed citations breakdown →

Xie, Changming, et al.. (2022). Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology. 57(9). 1070–1079. 8 indexed citations

Yan, Tao, et al.. (2022). Coronary Artery Disease and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study. Journal of Cardiovascular Development and Disease. 9(3). 69–69. 17 indexed citations

Yan, Tao, Shijie Zhu, Changming Xie, et al.. (2022). Dissecting the Association of Genetically Predicted Neuroticism with Coronary Artery Disease: A Two-Sample Mendelian Randomization Study. Journal of Personalized Medicine. 12(2). 288–288. 3 indexed citations

Liu, Kunpeng, Hao Li, Changming Xie, et al.. (2020). BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.. PubMed. 10(1). 78–94. 19 indexed citations

10.

Xie, Changming, et al.. (2019). Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?. BioMed Research International. 2019. 1–8. 6 indexed citations

11.

Xie, Changming, et al.. (2019). Development and validation of a preoperative prediction model for follicular thyroid carcinoma. Clinical Endocrinology. 91(2). 348–355. 5 indexed citations

12.

Zhang, Shuang, Hao Li, Changming Xie, et al.. (2019). Application of Continuous and Intermittent Intraoperative Nerve Monitoring in Thyroid Surgery. Journal of Surgical Research. 243. 325–331. 16 indexed citations

13.

Li, Dan, Chaoqun Wang, Wenjing Jiang, et al.. (2018). PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect. Cell Death and Disease. 9(5). 466–466. 60 indexed citations

14.

Xie, Changming, et al.. (2018). Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma. Journal of Endocrinological Investigation. 41(11). 1333–1338. 22 indexed citations

15.

Yang, Guangchao, Yingjian Liang, Tongsen Zheng, et al.. (2016). FCN2 inhibits epithelial–mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Cancer Letters. 378(2). 80–86. 69 indexed citations

16.

Li, Keyu, Jiabei Wang, Jihua Han, et al.. (2016). Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma. Oncotarget. 7(46). 76108–76117. 12 indexed citations

17.

Shi, Huawen, Guangchao Yang, Tongsen Zheng, et al.. (2015). A preliminary study of ALPPS procedure in a rat model. Scientific Reports. 5(1). 17567–17567. 37 indexed citations

18.

Zheng, Tongsen, Dalong Yin, Zhaoyang Lu, et al.. (2014). Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma. Molecular Cancer. 13(1). 133–133. 43 indexed citations

19.

Wang, Jiabei, Dalong Yin, Changming Xie, et al.. (2014). The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway. Oncotarget. 5(18). 8478–8491. 71 indexed citations

20.

Zhao, Yan, Yuan Liang, Luxi Li, et al.. (2014). [11beta-hydroxysteroid dehydrogenase type 2 enzyme activity effect after exposures phthalate esters in maternal].. PubMed. 48(9). 800–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact